Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis

NCT06999148 is registered in ClinicalTrials.gov with Yingjuan Zheng as lead sponsor.

NCT NCT06999148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06999148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis
Lead sponsor
Yingjuan Zheng
Phase
Phase 2
Overall status
Enrolling by invitation
Start date
October 1, 2024
Completion date
May 1, 2028
Enrollment
216 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma (any grade) in the brain